Skip to main content

Latest SEC Filings — Page 118

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

OnKure Therapeutics Secures $150M Private Placement, Extends Cash Runway to 2029, Mitigating Going Concern Doubt
ProForm 8-KOKUR · Form 8-K · 3d ago
Solid Power Reports Q1 Results, Confirms $121.3M Offering Proceeds, Advances Battery Tech
Form 8-KSLDP · Form 8-K · 3d ago
trivago Reports Strong Q1 Revenue Growth, Raises FY26 EBITDA Guidance, and Authorizes €20M Share Buyback
ProForm 6-KTRVG · Form 6-K · 3d ago
Contineum Therapeutics Reports Improved Q1 Financials, Extends Cash Runway to Mid-2029, and Advances Clinical Pipeline
ProForm 8-KCTNM · Form 8-K · 3d ago
Socket Mobile Reports 7% Q1 Revenue Decline, $0.9M Net Loss, Secures $0.5M Convertible Note for Working Capital
ProForm 8-KSCKT · Form 8-K · 3d ago
Jacobs Solutions Reports Strong Q2 Adjusted Results, Beats EPS Estimates, and Raises Full-Year Guidance
ProForm 8-KJ · Form 8-K · 3d ago
Flex to Spin Off Cloud & Power Infrastructure, Reports Strong Q4 & FY26 Results, Raises FY27 Guidance
ProForm 8-KFLEX · Form 8-K · 3d ago
Joby Aviation Reports Q1 2026 Results, Highlights Major Certification & Commercialization Milestones
ProForm 8-KJOBY · Form 8-K · 3d ago
InnovAge Reports Strong Q3 Results, Raises Full-Year Revenue and Adjusted EBITDA Guidance
ProForm 8-KINNV · Form 8-K · 3d ago
Rapid7 Reports Q1 2026 Results with Revenue Decline and Negative Guidance; $597M Convertible Notes Reclassified to Current Liabilities
ProForm 8-KRPD · Form 8-K · 3d ago
Trevi Therapeutics Secures $162M in April Offering, Extends Cash Runway into 2030
ProForm 10-QTRVI · Form 10-Q · 3d ago
Electronic Arts Reports Strong Q4 Results, Record FY26 Bookings, and Progress on $55B Acquisition
Form 8-KEA · Form 8-K · 3d ago
Suncrete Details Equity Component of Hope Concrete Acquisition, Including Potential $10M Earnout
Form 8-KRMIX · Form 8-K · 3d ago
Rush Street Interactive Announces Insider Stock Offering and Concurrent $130M Repurchase Program
ProForm FWPRSI · Form FWP · 3d ago
National Storage Affiliates Trust Reports Strong Q1 Earnings Amidst Public Storage Merger Preparations
ProForm 10-QNSA · Form 10-Q · 3d ago
Schrodinger's Q1 Report Reveals Strategic Drug Discovery Pivot and Major Validation from Eli Lilly's Ajax Acquisition
ProForm 10-QSDGR · Form 10-Q · 3d ago
Lucid Group Reports Deepening Losses and Increased Cash Burn in Q1, Secures Over $1.5B in New Capital
ProForm 10-QLCID · Form 10-Q · 3d ago
DaVita Reports Strong Q1 Results, Raises Full-Year Guidance, and Announces Significant Share Repurchases
ProForm 8-KDVA · Form 8-K · 3d ago
Qualys Reports Strong Q1 2026 Results and Raises Full-Year Revenue and EPS Guidance
Form 8-KQLYS · Form 8-K · 3d ago
Transocean Reports Strong Q1 Profitability, Revenue Growth, and Debt Reduction
ProForm 10-QRIG · Form 10-Q · 3d ago
Jazz Pharmaceuticals Reports Strong Q1 Profitability and 19% Revenue Growth
ProForm 10-QJAZZ · Form 10-Q · 3d ago
Farmer Mac Reports Strong Q1 Earnings with 18.5% Diluted EPS Growth and Significant Business Volume Expansion
ProForm 10-QAGM · Form 10-Q · 3d ago
Angi Inc. Repurchases $100M Debt, Appoints New COO & CAO Amidst Mixed Q1 Results
ProForm 8-KANGI · Form 8-K · 3d ago
Vertex Pharmaceuticals Reports Strong Q1 Earnings Driven by New Product Growth and Key Pipeline Progress
ProForm 10-QVRTX · Form 10-Q · 3d ago
Solventum Reports Strong Q1 Adjusted EPS, Raises Full-Year Guidance to High End of Range
Form 8-KSOLV · Form 8-K · 3d ago
Veracyte Reports Strong Q1 2026 Results, Exceeding Expectations and Raising Full-Year Guidance
ProForm 8-KVCYT · Form 8-K · 3d ago
Protagonist Therapeutics Reports Q1 Profit Driven by $250M in Milestone Payments and Extends Cash Runway
ProForm 8-KPTGX · Form 8-K · 3d ago
Super Micro Reports Mixed Q3 Results with Strong Margin Recovery but Significant Cash Burn; Q4 EPS Guidance Below Q3
ProForm 8-KSMCI · Form 8-K · 3d ago
Director & 10% Owner Marshall T. Reynolds Buys Nearly $1M in FGBI Stock, Reinforcing Insider Confidence
Form 4FGBI · Form 4 · 3d ago
Rigel Pharmaceuticals Reports Q1 Revenue Miss, Eli Lilly Terminates Collaboration
Form 8-KRIGL · Form 8-K · 3d ago